lamivudine has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Hao, Y; Li, M; Lu, Z; Tang, Q; Wang, Y; Zhang, J; Zhang, Q; Zhao, J | 1 |
| Arendt, G; Orhan, E; Schlonies, S; Stüve, O | 1 |
2 other study(ies) available for lamivudine and Cognitive Decline
| Article | Year |
|---|---|
Lamivudine improves cognitive decline in SAMP8 mice: Integrating in vivo pharmacological evaluation and network pharmacology.
Topics: Aging; Animals; Cognition; Cognitive Dysfunction; Lamivudine; Male; Mice; Neurodegenerative Diseases; Reverse Transcriptase Inhibitors | 2021 |
Simplification of combination antiretroviral therapy (cART) and the brain-a real-life experience.
Topics: Adult; Aging; Antiretroviral Therapy, Highly Active; Brain; Cognition; Cognitive Dysfunction; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Neuropsychological Tests; Quality of Life; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir | 2019 |